5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R.   Bouml s M.   Jenck F.   Kouml hler C.   Moreau J.-L.   Sleight A.J.   Stadler H.   Wichmann J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

Effects of the 5-HT 2C2B receptor agonist 1-(3-chlorophenyl)piperazine on plasma glucose levels of rats

By Sugimoto Y.   Yamada J.   Yoshikawa T.   Horisaka K.  

European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. : 75-80

Elsevier

Access to resources Recommend Favorite

Antidepressant-like effects of the novel, selective, 5-HT_2C receptor agonist WAY-163909 in rodents

By Rosenzweig-Lipson Sharon   Sabb Annmarie   Stack Gary   Mitchell Paul   Lucki Irwin   Malberg Jessica   Grauer Steve   Brennan Julie   Cryan John   Sukoff Rizzo Stacey   Dunlop John   Barrett James   Marquis Karen  

Psychopharmacology, Vol. 192, Iss. 2, 2007-06 ,pp. : 159-170

Springer Publishing Company

Access to resources Recommend Favorite

Characterisation of agonist binding on human 5-HT 2C receptor isoforms

By Quirk K.   Lawrence A.   Jones J.   Misra A.   Harvey V.   Lamb H.   Revell D.   Porter R.H.P.   Knight A.R.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Restraint accentuates the effects of 5-HT 2 receptor antagonists and a 5-HT 1A receptor agonist on lordosis behavior

By Uphouse L.   White S.   Harrison L.   Hiegel C.   Majumdar D.   Guptarak J.   Truitt W.A.  

Pharmacology Biochemistry and Behavior, Vol. 76, Iss. 1, 2003-08 ,pp. : 63-73

Elsevier

Access to resources Recommend Favorite